Drugs / DPCP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02640820 | Dec 2015 → Jan 2018 | common wart, human papilloma virus infection, plantar wart | RXi Pharmaceuticals, Corp. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DPCP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02640820 ↗ |
| Route | Topical | “An improved topical ointment formulation of DPCP called Samcyprone™ will be evaluated for the treatment of common warts.” NCT02640820 ↗ |